Condition: Attention Deficit Disorder With Hyperactivity (ADHD) · Sponsor: Adina Maeir
The goal of this study is to evaluate the feasibility and effectiveness of a health promotion intervention for Ultra-Orthodox Jewish mothers of children with ADHD. This study will examine the impact of a culturally tailored group-based intervention aimed at reducing stress, enhancing health, and improving the well-being of mothers. The main questions this study aims to answer are: 1. Is the intervention feasible for mothers to participate? 2. Does the intervention improve maternal knowledge about ADHD and reduce stigma? 3. Does it help reduce maternal stress and enhance self-care practices? Participants include: Mothers: Ultra-Orthodox Jewish mothers with a child (ages 6-12) diagnosed with ADHD and no other major health conditions in the family (other than ADHD). Educators: School educators with at least 5 years of experience teaching children with ADHD in the Ultra-Orthodox community. What participation involves: Mothers will attend six weekly teletherapy group sessions, with 6-8 mothers per group. They will complete questionnaires before and after the intervention (approximately 30 minutes each) and participate in a 90-minute remote focus group to provide feedback on the program. Educators will attend a single teletherapy group session (90 minutes) during the program (session 5) and participate in a 90-minute remote interview to provide feedback on the program.
This description comes directly from the study's public registry record.
Jennifer Budman, PhD · 972 503422600 · jennifer.budman@mail.huji.ac.il
Always discuss trial participation with your own doctor first.
| Hebrew University | Jerusalem, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06703242